118 related articles for article (PubMed ID: 3117104)
1. A covalent molecular weight approximately 92,000 hybrid plasminogen activator derived from human plasmin fibrin-binding and tissue plasminogen activator catalytic domains.
Robbins KC; Boreisha IG
Biochemistry; 1987 Jul; 26(15):4661-7. PubMed ID: 3117104
[TBL] [Abstract][Full Text] [Related]
2. Covalent molecular weight approximately 92 000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domains.
Robbins KC; Tanaka Y
Biochemistry; 1986 Jun; 25(12):3603-11. PubMed ID: 2941075
[TBL] [Abstract][Full Text] [Related]
3. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
Bakker AH; Nieuwenbroek NM; Verheijen JH
Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator.
Gheysen D; Lijnen HR; Piérard L; de Foresta F; Demarsin E; Jacobs P; De Wilde M; Bollen A; Collen D
J Biol Chem; 1987 Aug; 262(24):11779-84. PubMed ID: 3114253
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of covalent hybrid plasminogen activators: effect of CNBr-degraded fibrinogen on kinetic parameters of Glu1-plasminogen activation.
Lee PP; Wohl RC; Boreisha IG; Robbins KC
Biochemistry; 1988 Sep; 27(19):7506-13. PubMed ID: 2974723
[TBL] [Abstract][Full Text] [Related]
6. Construction and expression of hybrid plasminogen activators prepared from tissue-type plasminogen activator and urokinase-type plasminogen activator genes.
Lee SG; Kalyan N; Wilhelm J; Hum WT; Rappaport R; Cheng SM; Dheer S; Urbano C; Hartzell RW; Ronchetti-Blume M
J Biol Chem; 1988 Feb; 263(6):2917-24. PubMed ID: 3125172
[TBL] [Abstract][Full Text] [Related]
7. Tissue-type plasminogen activator and its substrate Glu-plasminogen share common binding sites in limited plasmin-digested fibrin.
de Vries C; Veerman H; Koornneef E; Pannekoek H
J Biol Chem; 1990 Aug; 265(23):13547-52. PubMed ID: 2143185
[TBL] [Abstract][Full Text] [Related]
8. The position of the structurally autonomous kringle 2 domain influences the functional features of tissue-type plasminogen activator.
Bakker AH; Rehberg EF; Marotti KR; Verheijen JH
Protein Eng; 1995 Mar; 8(3):293-300. PubMed ID: 7479691
[TBL] [Abstract][Full Text] [Related]
9. Artificial exon shuffling between tissue-type plasminogen activator (t-PA) and urokinase (u-PA): a comparative study on the fibrinolytic properties of t-PA/u-PA hybrid proteins.
de Vries C; Veerman H; Blasi F; Pannekoek H
Biochemistry; 1988 Apr; 27(7):2565-72. PubMed ID: 3132969
[TBL] [Abstract][Full Text] [Related]
10. Localization of the binding sites of porcine tissue-type plasminogen activator and plasminogen to heparin.
Soeda S; Kakiki M; Shimeno H; Nagamatsu A
Biochim Biophys Acta; 1987 Dec; 916(3):279-87. PubMed ID: 3120775
[TBL] [Abstract][Full Text] [Related]
11. Effects of monoclonal antibodies on tissue-type plasminogen activator (t-PA) binding to lysine, fibrin and heparin and on fibrin-mediated enhancement of one-chain t-PA amidolytic activity.
Fischer B; Zacharias U; Will H
Biol Chem Hoppe Seyler; 1991 Apr; 372(4):263-71. PubMed ID: 1905550
[TBL] [Abstract][Full Text] [Related]
12. Replacement of finger and growth factor domains of tissue plasminogen activator with plasminogen kringle 1. Biochemical and pharmacological characterization of a novel chimera containing a high affinity fibrin-binding domain linked to a heterologous protein.
Langer-Safer PR; Ahern TJ; Angus LB; Barone KM; Brenner MJ; Horgan PG; Morris GE; Stoudemire JB; Timony GA; Larsen GR
J Biol Chem; 1991 Feb; 266(6):3715-23. PubMed ID: 1847387
[TBL] [Abstract][Full Text] [Related]
13. Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli.
Wilhelm OG; Jaskunas SR; Vlahos CJ; Bang NU
J Biol Chem; 1990 Aug; 265(24):14606-11. PubMed ID: 2117612
[TBL] [Abstract][Full Text] [Related]
14. Localization of the binding site of tissue-type plasminogen activator to fibrin.
Ichinose A; Takio K; Fujikawa K
J Clin Invest; 1986 Jul; 78(1):163-9. PubMed ID: 3088041
[TBL] [Abstract][Full Text] [Related]
15. Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments.
de Munk GA; Caspers MP; Chang GT; Pouwels PH; Enger-Valk BE; Verheijen JH
Biochemistry; 1989 Sep; 28(18):7318-25. PubMed ID: 2510823
[TBL] [Abstract][Full Text] [Related]
16. Binding of one-chain tissue-type plasminogen activator to fibrin, partially plasmin-degraded fibrin, lysine and heparin.
Fischer B
Biomed Biochim Acta; 1991; 50(1):47-54. PubMed ID: 1830477
[TBL] [Abstract][Full Text] [Related]
17. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
Weitz JI; Leslie B; Ginsberg J
J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
[TBL] [Abstract][Full Text] [Related]
18. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
Grailhe P; Boyer-Neumann C; Haverkate F; Grimbergen J; Larrieu MJ; Anglés-Cano E
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717
[TBL] [Abstract][Full Text] [Related]
19. Structure-function analysis with tissue-type plasminogen activator. Effect of deletion of NH2-terminal domains on its biochemical and biological properties.
Kalyan NK; Lee SG; Wilhelm J; Fu KP; Hum WT; Rappaport R; Hartzell RW; Urbano C; Hung PP
J Biol Chem; 1988 Mar; 263(8):3971-8. PubMed ID: 3126183
[TBL] [Abstract][Full Text] [Related]
20. Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface.
Fleury V; Loyau S; Lijnen HR; Nieuwenhuizen W; Anglés-Cano E
Eur J Biochem; 1993 Sep; 216(2):549-56. PubMed ID: 8375393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
